Supplementary Materials

The PDF file includes:

  • Fig. S1. Seroreactivity of the SARS-CoV-2 tri-S ELISA assay
  • Fig. S2. Seroreactivity of the S-Flow assay
  • Fig. S3. Seroreactivity of the SARS-CoV-2 LIPS assays
  • Fig. S4. Characteristics of the pseudovirus neutralization assay
  • Table S1. Clinical status of hospitalized patients with COVID-19
  • Table S2. Characteristics of mildly-symptomatic individuals with suspected SARS-CoV-2 infection

[Download PDF]

Other Supplementary Material for this manuscript includes the following: